Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
…, D Görlich, S Schneider, NP Konstandin… - Blood, The Journal …, 2016 - ashpublications.org
The clinical and prognostic relevance of many recently identified driver gene mutations in
adult acute myeloid leukemia (AML) is poorly defined. We sequenced the coding regions or …
adult acute myeloid leukemia (AML) is poorly defined. We sequenced the coding regions or …
Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations
…, N Gökbuget, D Hoelzer, NP Konstandin… - Blood, The Journal …, 2013 - ashpublications.org
Early T-cell precursor (ETP) acute lymphoblastic leukemia (ALL) is a high-risk subgroup of T-lineage
ALL characterized by specific stem cell and myeloid features. In adult ETP-ALL, no …
ALL characterized by specific stem cell and myeloid features. In adult ETP-ALL, no …
[HTML][HTML] Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
…, H Janke, D Goerlich, MC Sauerland, NP Konstandin… - Leukemia, 2020 - nature.com
The revised 2017 European LeukemiaNet (ELN) recommendations for genetic risk stratification
of acute myeloid leukemia have been widely adopted, but have not yet been validated in …
of acute myeloid leukemia have been widely adopted, but have not yet been validated in …
[HTML][HTML] Adults with Philadelphia chromosome–like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual …
…, L Hartmann, KG Roberts, NP Konstandin… - …, 2017 - ncbi.nlm.nih.gov
Philadelphia-like B-cell precursor acute lymphoblastic leukemia (Ph-like ALL) is characterized
by distinct genetic alterations and inferior prognosis in children and younger adults. The …
by distinct genetic alterations and inferior prognosis in children and younger adults. The …
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia
PA Greif, A Dufour, NP Konstandin… - Blood, The Journal …, 2012 - ashpublications.org
Cytogenetically normal acute myeloid leukemia (CN-AML) with biallelic CEBPA gene mutations
(biCEPBA) represents a distinct disease entity with a favorable clinical outcome. So far, …
(biCEPBA) represents a distinct disease entity with a favorable clinical outcome. So far, …
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia
…, S Amler, D Goerlich, T Köhnke, NP Konstandin… - Leukemia, 2017 - nature.com
Some patients with acute myeloid leukemia (AML) who are in complete remission after
induction chemotherapy harbor persisting pre-leukemic clones, carrying a subset of leukemia-…
induction chemotherapy harbor persisting pre-leukemic clones, carrying a subset of leukemia-…
[HTML][HTML] RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes
… Greif, 1, 2 Nikola P. Konstandin, 1, 2 Klaus H. Metzeler, 1 Tobias Herold, 1 Zlatana
Pasalic, 1 Bianka Ksienzyk, 1 Annika Dufour, 1 Friederike Schneider, 1 Stephanie …
Pasalic, 1 Bianka Ksienzyk, 1 Annika Dufour, 1 Friederike Schneider, 1 Stephanie …
[HTML][HTML] Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older
…, T Herold, H Janke, B Ksienzyk, NP Konstandin… - …, 2018 - ncbi.nlm.nih.gov
A cute myeloid leukemia is a disease of the elderly (median age at diagnosis, 65–70 years).
The prognosis of older acute myeloid leukemia patients is generally poor. While genetic …
The prognosis of older acute myeloid leukemia patients is generally poor. While genetic …
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody
…, V Lyamichev, J Patel, N Konstandin… - Blood, The Journal …, 2021 - ashpublications.org
Antibody-based immunotherapy is a promising strategy for targeting chemoresistant leukemic
cells. However, classical antibody-based approaches are restricted to targeting lineage-…
cells. However, classical antibody-based approaches are restricted to targeting lineage-…
[HTML][HTML] A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia
…, H Blum, S Amler, S Schneider, N Konstandin… - …, 2018 - ncbi.nlm.nih.gov
Primary therapy resistance is a major problem in acute myeloid leukemia treatment. We set
out to develop a powerful and robust predictor for therapy resistance for intensively treated …
out to develop a powerful and robust predictor for therapy resistance for intensively treated …